Current Report · Items 5.02 · 8-K

SS Innovations International Inc.

SSIINASDAQEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Filed Aug 26, 2026Accepted Aug 26, 2026, 4:05 PM EDTCIK 1676163Accession 0001213900-26-093946

Company context

We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. We design, manufacture and market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the “SSi Mantra”) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries. While surgical robotic systems have gained acceptance globally in the past two decades for providing greater efficiency, better clinical outcomes and reducing healthcare costs, access to such systems remains largely limited to developed countries such as the United States (the “U.S.”), the European Union (the “EU”) and Japan. With the SSi Mantra, we are breaking down barriers and accelerating access to surgical robotics technologies in underserved regions of the world.

Current securities

SSIINASDAQ · EQUITY · Current

Historical securities (3)

AVMROTC · EQUITY · Historical · closed Apr 17, 2023 AVMRDOTC · EQUITY · Historical · closed May 15, 2023 SSIIOTC · EQUITY · Historical · closed Apr 25, 2025

Recent company filings

Registered securities in this filing

SS INNOVATIONS INTERNATIONAL, INC. · 8-K · Filed 2026-08-26

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock

Symbol: SSII
Exchange: NASDAQ
Classification: COMMON

Filing context

Context: AsOf2026-08-21

Dimensions: Not supplied

Accession 000121390026093946 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.02

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective August 21, 2026, Sarah Romano is no longer serving as Chief Financial Officer of the Company. Ms. Romano's departure was not the result of any disagreement with the Company on any matter relating to the Company's financial reporting, internal controls, operations, policies, or accounting practices.

Get the free weekly BCS email.